JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3126
Cogent Biosciences
COGT
$5.27B
| $2.91M | ﹤0.01% |
269,493
+28,073
| +12% | +$359K |
2020 Q4
9 quarters
|
|
3127
Chefs' Warehouse
CHEF
$4.54B
| $2.9M | ﹤0.01% |
85,166
+28,666
| +51% | +$1.01M |
2017 Q4
21 quarters
|
|
3128
Agilysys
AGYS
$2.79B
| $2.89M | ﹤0.01% |
35,057
+5,755
| +20% | +$465K |
2015 Q4
29 quarters
|
|
3129
Replimune Group
REPL
$1.25B
| $2.88M | ﹤0.01% |
163,210
+10,518
| +7% | +$250K |
2018 Q3
18 quarters
|
|
3130
Robinhood
HOOD
$101B
| $2.88M | ﹤0.01% |
296,515
+40,486
| +16% | +$386K |
2021 Q3
6 quarters
|
|
|
HBI
3131
DELISTED
Hanesbrands
HBI
| $2.87M | ﹤0.01% |
546,484
-150,551
| -22% | -$947K |
2013 Q2
39 quarters
|
|
3132
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.62B
| $2.86M | ﹤0.01% |
43,744
-13,386
| -23% | -$844K |
2022 Q4
1 quarter
|
|
3133
indie Semiconductor
INDI
$661M
| $2.86M | ﹤0.01% |
271,338
+17,896
| +7% | +$160K |
2021 Q4
5 quarters
|
|
3134
Healthcare Services Group
HCSG
$1.45B
| $2.85M | ﹤0.01% |
205,579
+12,520
| +6% | +$165K |
2013 Q2
39 quarters
|
|
3135
Equity Bancshares
EQBK
$978M
| $2.85M | ﹤0.01% |
116,983
-21,945
| -16% | -$647K |
2017 Q3
22 quarters
|
|
|
PRO
3136
DELISTED
PROS Holdings
PRO
| $2.84M | ﹤0.01% |
103,756
+6,798
| +7% | +$177K |
2017 Q3
22 quarters
|
|
|
OPLN
3137
Openlane
OPLN
$4.27B
| $2.84M | ﹤0.01% |
207,582
+19,535
| +10% | +$271K |
2013 Q2
39 quarters
|
|
|
BRMK
3138
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
| $2.84M | ﹤0.01% |
603,096
+404,753
| +204% | +$1.79M |
2020 Q2
11 quarters
|
|
|
RTL
3139
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $2.84M | ﹤0.01% |
451,576
-150,129
| -25% | -$973K |
2018 Q4
17 quarters
|
|
3140
BlackBerry
BB
$5.62B
| $2.82M | ﹤0.01% |
618,401
+409,887
| +197% | +$1.63M |
2013 Q2
39 quarters
|
|
3141
Beazer Homes USA
BZH
$891M
| $2.82M | ﹤0.01% |
177,595
-3,426
| -2% | -$50.8K |
2015 Q4
29 quarters
|
|
3142
U.S. Small Cap Portfolio ETF Class Shares
DFAS
$15.2B
| $2.81M | ﹤0.01% |
53,400
+9,734
| +22% | +$527K |
2022 Q4
1 quarter
|
|
3143
Palomar
PLMR
$3.34B
| $2.81M | ﹤0.01% |
50,942
+19,168
| +60% | +$1.03M |
2019 Q2
15 quarters
|
|
3144
Immunocore
IMCR
$1.52B
| $2.81M | ﹤0.01% |
56,730
-56,749
| -50% | -$3.19M |
2022 Q2
3 quarters
|
|
3145
Coeur Mining
CDE
$17.6B
| $2.8M | ﹤0.01% |
700,765
+245,497
| +54% | +$852K |
2013 Q2
39 quarters
|
|
3146
Marcus & Millichap
MMI
$1.08B
| $2.78M | ﹤0.01% |
86,567
+25,237
| +41% | +$876K |
2017 Q4
21 quarters
|
|
3147
Myers Industries
MYE
$1.2B
| $2.77M | ﹤0.01% |
129,478
+26,675
| +26% | +$607K |
2013 Q2
39 quarters
|
|
3148
Blue Owl Capital
OBDC
$4.95B
| $2.77M | ﹤0.01% |
220,089
+64,908
| +42% | +$835K |
2021 Q4
5 quarters
|
|
3149
Cartesian Therapeutics
RNAC
$204M
| $2.77M | ﹤0.01% |
66,536
-845
| -1% | -$39.7K |
2020 Q2
11 quarters
|
|
3150
Transportadora de Gas del Sur
TGS
$4.07B
| $2.77M | ﹤0.01% |
+270,784
| New | +$2.92M |
2023 Q1
0 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.